Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
0.995
-0.025 (-2.46%)
Dec 3, 2024, 1:49 PM EST - Market open
Jaguar Health Employees
Jaguar Health had 49 employees as of December 31, 2023. The number of employees decreased by 11 or -18.33% compared to the previous year.
Employees
49
Change (1Y)
-11
Growth (1Y)
-18.33%
Revenue / Employee
$213,878
Profits / Employee
-$770,245
Market Cap
11.74M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 1,003 |
Evogene | 142 |
T2 Biosystems | 113 |
STRATA Skin Sciences | 99 |
MSP Recovery | 88 |
Turnstone Biologics | 80 |
BiomX | 71 |
Vaccinex | 40 |
JAGX News
- 8 days ago - Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference - Accesswire
- 11 days ago - Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs - Accesswire
- 14 days ago - Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe” - Accesswire
- 17 days ago - Jaguar Health, Inc. (JAGX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Jaguar Health Reports Third Quarter 2024 Financial Results - Accesswire
- 22 days ago - Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates - Accesswire
- 27 days ago - FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea in Dogs - Accesswire
- 4 weeks ago - Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS) - Accesswire